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!~18--~-6~ Particular Benefit of Platelet GPllb/llla Blockade 
. . . . .  and Full Heparln In Patients With Peripheral 
Vascular Disease Undergoing PTCA 
J ,M  MIII0r, N, Goalmy, C Balog, A.M Lmcofl. E J  Topoi Duke Umve~s~ty 
M~tC,~tI C~..nter, Ctel,.elar~ Clinic Foun~=~hon. USA 
AthetO~lototic vascular (llsoase may clintcally manifest as coronary, c~re. 
bral, or I~nphoral disease, but all fmms appear to benefit from antiplafetet 
therapy We hypothesized that pIS with peephefal vascular d~sease (PVD) 
who were undergoing coronary angroplasty as parl el the EPILOG Iris! wouM 
h~ n greater treatment 0ffecl from at~iximab (ciTE31 than thc~c w/o PVD 
PIs wtth PVD (n =~ 305) were older, heavier, more omen female, with hyperion. 
SlO0: (~abete~ and pnor PTCA Among PVD ptS, those randomized to ¢~3-  
standard do~e hepann (n = t06i had a lower event rate when compare0 
with placebo . hel~lnn |199% VS 306%, p = 00,5) than C7E3 * tow ~e 
hel~nn (29(P~,, p ~ 0 66) In non~PVD pts (n = 2446) the combmec! eno'po~nt 
el death, MI, r~asculanzal~on at 6 months was 2~ 5% for pts receiving c7E3 
• hep~nn ~t~ 25% in pla4:ebo • hepann (p = 0 08) There was no in~reaso ~n 
n~or  bteed~og or stroke in PVD pls 
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Cot~ctu~n The presence of PVD apl~ars to I~ a marker of ~mpro.~ed 
bewef;,t from c7E3 + standard do~e hepann treatment dunng coronary inter- 
vention 
• Balloon Angioplasty Versus Oebulkin 9 for 
Treatment  o f  D i f fuse  In-stent Reslenosls 
HL. Daueffnan. DS Balm. AM Sparano, C.M. Gibson, RE  Kuntz. 
J.P Carrozza Jr. DJ. Cohen. Beth Israel Deaconess Medical Center. 
Boston. Mass. USA 
Background Balloon ar~oplasty (BAt for drttuse (n-stent restet-,os~s ~s::rts 
=n h~Jh rates el target vessel re~eulanzat~on tTVR) possibly retate~3 to 
rt..--s~,~ua| plaque burden. By reducing this ptaqu~ burden, c~13ulP~=r,.g m~ght 
Improve C{m,,~al Outcomes 
Meffmds We compared BA aJone (n = 30) or debut',~ncj by rotahonal In 
= 26~ Or directional in = 4) atherectomy . BAm 60 coc~ec~h~e patients 
undergoing treatment of ~ttuse ~n steel restenesls 
ResultS: Basehne charactenstics were similar lay quan~atwe coronary 
an~jrapby.  Procedural s~',cess was I00%, wtth no comphcatlon~ and 
no increase m non-Q wave MI dlssed[on of "no-fellow" tn the debulkmg 
group Debulkmg * BA resulted in sig~itlcantiy lower best-procedure residual 
stenoses and improved flow rates SLX month follow- up was available for 
all patients and showed a strong trend towards less TVR ~,~,'h c~b~tkmg 
Independent pred=doP3 el repeat TVR were a smaller hnal mm~mum luminal 
diameter (p = 0 007) and longer les~on length iP = 00(36) 
PTCA Oel3uiktr~l • PTCA P value 
Les~nten~thlmml It 8 : 8 1 94 : 46 NS 
Rete=e~,ce ~e~el mrr,) 2 8 : 0 6 2 O : O 6 NS 
Stenos=sprel%) 809 ~ 132 78 7 : 114 NS 
Stenostsposll%l 25 : 13 18 : 10 eel 
Flnalhamoc(Junl 114 : 2S ~]{} : 24 oeet 
One year TVR 46% 28% 0 t8 
Concluston~: 1 ) For treatment of d~ffuse in stent restenosts, debuIking 
BA is safe and leads to a lower residual stenoscs than BA alone. 2 ) Since a 
larger final MLD predicts less TVR. a debulking strategy may be the treatment 
ot choice for diffuse in stent restenosis 
• Mechanisms and Results of Additional Stent 
implantation to Treat Focal In-stent Restenosis 
R. Mehran. A.S Abizaid. G.S. Mintz, A. Abizaid, AJ. Lansky. K.M, Kent, 
L.F. Satlet. AD. Picha~. TA. Bucher, J J. Popma, M.B. Leon. Washington 
Hospital Center. Washington, DC, USA 
Focal restenosis within Palmaz-Schatz stents is usually treated with repeat 
PTCA; using intravascular ultrasound (IVUS), the increase in lumen area 
has been shown to be a combination o1 tissue extrusion and additional stent 
expansion with significant residual neointimal tissue. In an attempt o further 
reduce the need for subsequent target lesion revasculadzation, 56 focal 
restenotic stented lesions (21 vein graft, 35 native vessel) in 51 pts were 
treated with additional Plamaz.Schatz stem =mpl~m~bon Pattern~ of tO(~l 
re-sleet restono~,ls wore Identltlod angtograph~call t ~nd (:onhfn-~l wdh IVUS 
27 at one of the margins, 19 at the c:ontral arbcutahon and 10 w0hm the body 
Angtogtaphic Ioston t0ngth measure0 6 9 = 1 8 mm IVUS rnea~uremems 
Ot sleet lumeL and mhmat hyperplasla (IH) aroa~ pfe* aed Post,addltlonal 
slenl Implanlabon wore used t0 assess, mo~h.~ni~m5 ot tu~ ef~laf~j~rr~nl 
. . . . . . .  p 
Mlnlmt~m iumen ,~e~ Im, mPi t f) z O 7 7 5 ~ p 2' 0 (~:~J !
IH ~ea I~am 21 5, 7 ~ I h 0 ? ~ 0 3 I:~ 0(1{ I
~. IH area P~E~,~SUr.-----------------O~ 50 ~ t 7 mm ~ (or 85 ~ 11% 0l -~ lumen area), 
¢onvemety, b, stent area measutc-d only 09  -, 0 4 ram: Residual IH are~ wa~ 
9 : 2% ot final lumen area. F,nat anglog~ph¢ d*ameter stenos=s measured 
10 ~ 12% Target les,on revascu!arlzat~on at I yr was 27%. 
We Conct~e In line treatment el fOcatin.slent restenos~s, add0~onal stem 
tmplanlatlon increased lumen area pemanly by neomtimal tissue e~l[u~on 
with ~urprmmgly little add~tlor,al steer expansion Although hnal ~arr~ett~ 
steno~=~ t10%) and re~=dual neomt~mal tissue (9%) were tow, TLR at t yr 
wa~ 27% 
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Elevat~n ot CK-MB occurs frequently after rotational atherectomy (ROTe) 
STRATAS was a 500 patient rand~rntzed comparison of two ROTe ~rate- 
g(es CPK. CK-MB (CKMBR - ratio of normal) and ECGs were prosl:~-'llvely 
collected and a~tud=eated by a bhndea core laboratory into 3 MI care ~ones 
Type I. CKMBR . 1 and 3: Type 2, CKMBR , 1 and - 3 wrth ST abt ~rnal- 
itios o~ CKMBR :3 and 8; or. T~,}e 3, Q wave MI or CKMBR ,8 levee 
patients W~l emergent CAE]G or .,eaYh w~th~n 24 hours of the prt. edure 
were e~ctt.ld'~3 from analys.s ;,, ,3 ,,~ :lhvanate model el CK elevatlG,, only 
the presence of no retto~ !:_~-:~r~ ~brupt ctO=-ure, s=deDranch ~klg=l~tll 
larger final MLD an~l moderate to heavy cak:mm were ~l-.3epende.t pre- 
dtctors More aggressive ROTe. age gender, ~rabetas and HTN were net 
predlclors Nine , '~onlh follow-up iS available tot 85'~ of the patlenls There 
W~ r,o assoc,atl~Jn ot MI and late dea~'l (p = 0 3,4) or a composite of la~e 
aeath, recurrent MI or repeat revascutarlzat)en (p = 064)  
Em~p~mr NO M; Any MI Type t Type 2 Type 3 
n ~,~ 330 ~ 71i 134 leg) 65 (141 4319) 2fi 16) 
~lea~ 7 !2 1 ) 513 7) :314 61 2 i4 6l 0 l0 O) 
CGmp,~5:!~ r17!35 5! ~,3 !~ %l ~S ~3,R 5) It., (3491 13 (~e] 
Conctuszon. MI occurs frequently after ROTe and ~s predicted by anqlo 
graphic comply:sirens, vessel calclficatTon and a larger hnal MLD There Js 
no assoctatron Ot MI and late mortahty or TVF 
[ 1 1 89-60  t The Impact of ReoPro or Lower Speeds on 
Platelet Aggregation During Rotational 
Atherectomy 
M. Reisman. S Speck. J L Petersen. R J Westcott. R Fel. V Harms, 
S. Bogoslan. O Oillard, B Shuman Swedzsh Medlc.tl Center and BSC 
Northwest Technology Center. Se~rRle. WA. USA 
Rotational atherec?omy is associated with an nncreased incidence of slow 
flow and creahne kmase elevatton which ~s reduced by ReePro, tmpffcatmg 
platelet activation as a potential mechanism. This study tests the effects 
el burr speed or ReoPro on piatetet aggregation asmg an =n vwtre model. 
A 2.0 mm Rotablator" burr was rotated in 2.5 mm inner diameter silicone 
tubing. Hepannized human blood was pumped through the tubing at 10 
cc/min, and subjected to ablation speeds o! 180,000 rpm, 140,000 rpm and 
0 (control). ReoPro (5 /,glml) was mixed wire blood for 5 min. and the 
test at 180,000 rpm was repeated. The blood was collected and analyzed 
immediately lor the quantity and size of platelet aggregates using an optical 
